[
    [
        {
            "time": "2018-01-02",
            "original_text": "Dividend Consumer Stocks to Buy for Income amp; Growth",
            "features": {
                "keywords": [
                    "Dividend",
                    "Consumer",
                    "Stocks",
                    "Income",
                    "Growth"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "consumer goods"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dividend Consumer Stocks to Buy for Income amp; Growth",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-05-14",
            "original_text": "Coronavirus update: US jobless numbers amplify reopening debate; US, NY case split grows",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "US",
                    "jobless",
                    "numbers",
                    "reopening",
                    "debate",
                    "NY",
                    "case",
                    "split"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 10,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-05-10",
            "original_text": "Theravance (TBPH) Q1 Earnings Miss, Revenues Beat Estimates",
            "features": {
                "keywords": [
                    "Theravance",
                    "TBPH",
                    "Q1",
                    "Earnings",
                    "Miss",
                    "Revenues",
                    "Beat",
                    "Estimates"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-04-07",
            "original_text": "Is Abbott A Buy After Launching Not One — But Three — Coronavirus Tests?",
            "features": {
                "keywords": [
                    "Abbott",
                    "Buy",
                    "Launching",
                    "Coronavirus",
                    "Tests"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-05-15",
            "original_text": "NYSE President Stacey Cunningham joins 'Influencers with Andy Serwer'",
            "features": {
                "keywords": [
                    "NYSE",
                    "President",
                    "Stacey",
                    "Cunningham",
                    "Influencers",
                    "Andy",
                    "Serwer"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-05-12",
            "original_text": "Bristol Myers sees 2020 earnings holding despite coronavirus pandemic",
            "features": {
                "keywords": [
                    "Bristol",
                    "Myers",
                    "2020",
                    "earnings",
                    "holding",
                    "coronavirus",
                    "pandemic"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]